Effect of clotrimazole on microsomal metabolism and pharmacokinetics of albendazole

Journal of Pharmacy and Pharmacology

Volumn 55, Issue 6, 2003, Pages 757-764

  Merino, G ^a   Molina, A J ^a   Garcia J L ^a   Pulido, M M ^a   Prieto, J G ^a   Alvarez, A I ^a  

^a UNIVERSITY OF LEÓN   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

ALBENDAZOLE; ALBENDAZOLE SULFONE; ALBENDAZOLE SULFOXIDE; ANTHELMINTIC AGENT; BENZIMIDAZOLE DERIVATIVE; CLOTRIMAZOLE; DRUG METABOLITE; INTESTINE ENZYME;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; AREA UNDER THE CURVE; ARTICLE; CONTROLLED STUDY; DOSE RESPONSE; DRUG BLOOD LEVEL; DRUG EFFECT; DRUG EXPOSURE; DRUG HALF LIFE; DRUG INHIBITION; DRUG METABOLISM; ENZYME ACTIVITY; IN VITRO STUDY; INTESTINE; LIVER; LIVER MICROSOME METABOLISM; LONG TERM CARE; MALE; MEAN RESIDENCE TIME; METABOLIC INHIBITION; NONHUMAN; RAT; RAT STRAIN;

ADMINISTRATION, ORAL; ALBENDAZOLE; ANIMALS; ANTHELMINTICS; ANTIFUNGAL AGENTS; AREA UNDER CURVE; BIOTRANSFORMATION; CLOTRIMAZOLE; DRUG INTERACTIONS; HALF-LIFE; LIVER; MALE; RATS; RATS, WISTAR;

EID: 0038544454     PISSN: 00223573     EISSN: None     Source Type: Journal    
DOI: 10.1211/002235703765951357     Document Type: Article

References (39)

1. Bailey, D. G., Malcolm, J., Arnold, O., Spence, J. D. (1998) Grape fruit juice-drug interactions. Br. J. Clin. Pharmacol. 46: 101-110
2. Bennett, A., Guyatt, H. (2000) Reducing intestinal nematode infection: Efficacy of albendazole and mebendazole. Parasitol. Today 16: 71-74
3. Costa, S. F., Weiss, L. M. (2000) Drug treatment of microsporidiosis. Drug Resist. Updat. 3: 384-399
4. Cox, F. E. G. (2000) Elimination of lymphatic filariasis as a public health problem. Parasitol. Today 16: 135
5. Delatour, P., Benoit, E., Besse, S., Boukraa, A. (1991) Comparative enantioselectivity in the sulphoxidation of albendazole in man, dogs and rats. Xenobiotica 21: 217-221
6. Dupuy, J., Huet, A. M., Birckel, P., Weil, A., Alvinerie, M., Galtier, P. (1997) Major involvement of liver cytochrome P4503A subfamily in fipronil sulfonation. Proceedings of the 7th EAVPT International Congress, p. 104
7. Eliasson, E., Mkrtchian, S., Halpert, J. R., Ingelman-Sundberg, M. (1994) Substrate-regulated, cAMP-dependent phosphorylation, denaturation, and degradation of glucocorticoid-inducible rat liver cytochrome P4503A1. J. Biol. Chem. 269: 18378-18383
8. Emoto, C., Yamazaki, H., Iketaki, H., Yamasaki, S., Satoh, T., Shimizu, R., Suzuki, S., Shimada, N., Nakajima, M., Yokoi, T. (2001) Cooperativity of α-naphthoflavone in cytochrome P450 3A-dependent drug oxidation activities in hepatic and intestinal microsomes from mouse and human. Xenobiotica 31: 265-275
9. Galtier, P., Alvinerie, M., Delatour, P. (1986) In vitro sulfoxidation of albendazole by ovine liver microsomes. Am. J. Vet. Res. 47: 447-450.
10. Gibaldi, M. (1991) Compartmental and noncompartmental pharmacokinetics. In: Biopharmaceutics and Clinical Pharmacokinetics. 4th Edn. Lea & Febiger, London, pp 14-23
11. Gibbs, M. A., Kunze, K. L., Howald, W. N., Thummel, K. E. (1999) Effect of inhibitor depletion on inhibitor potency: Tight binding inhibition of CYP3A by clotrimazole. Drug Metab. Dispos. 27: 596-599
12. Gil-Grande, L. A., Rodríguez-Caabeiro, F., Prieto, J. G., Sánchez-Ruano, J. J., Brasa, C., Aguilar, L., García-Hoz, F., Casado, N., Bárcena, R., Álvarez, A. I., Dal-Ré, R. (1993) Randomised controlled trial of efficacy of albendazole in intra-abdominal hydatid disease. Lancet 342: 1269-1272
13. Harmsworth, W. L., Franklin, M. R. (1990) Induction of hepatic and extrahepatic cytochrome P-450 and monooxygenase activities by N-substituted imidazoles. Xenobiotica 20: 1053-1063
14. Horton, R. J. (1997) Albendazole in treatment of human cystic echinococcosis: 12 years of experience. Acta Trop. 1: 79-93
15. Hostetler, K. A., Wrighton, S. A., Molowa, D. T., Thomas, P. E., Levin, W., Guzelian, P. S. (1989) Coinduction of multiple hepatic cytochrome P-450 proteins and their mRNAs in rats treated with imidazole antimycotic agents. Mol. Pharmacol. 35: 279-285
16. Lanusse, C. E., Nare, B., Prichard, R. K. (1993) Comparative sulphoxidation of albendazole by sheep and cattle liver microsomes and the inhibitory effect of methimazole. Xenobiotica 23: 285-295
17. Lin, J. H., Chiba, M., Baillie, T. A. (1999) Is the role of the small intestine in first-pass metabolism overemphasized? Pharmacol. Rev. 51: 135-157
18. Lown, K. S., Kolars, J. C., Thummel, K. E., Barnett, J. L., Kunze, K. L., Wrighton, S. A., Watkins, P. B. (1994) Interpatient heterogeneity in expression of CYP3A4 and CYP3A5 in small bowel. Lack of prediction by the erythromicin breath test. Drug Metab. Dispos. 22: 947-955
19. Lowry, O. H., Rosebrough, N. J., Farr, A. L., Randall, R. J. (1951) Protein measurement with the folin phenol reagent. J. Biol. Chem. 193: 265-275
20. Maurice, M., Pichard, L., Daujat, M., Fabre, I., Joyeux, H., Domergue, J., Maurel, P. (1992) Effects of imidazole derivatives on cytochromes P450 from human hepatocytes in primary culture. FASEB J. 6: 752-758
21. McKellar, Q. A., Jackson, F., Coop, R. L., Baggot, J. D. (1993) Plasma profiles of albendazole metabolites after administration of netobimin and albendazole in sheep: Effects of parasitism and age. Br. Vet. J. 149: 101-113
22. Merino, G., Álvarez, A. I., Redondo, P. A., García, J. L., Larrodé, O. M., Prieto, J. G. (1999) Bioavailability of albendazole sulphoxide after netobimin administration in sheep: Effects of fenbendazole coadministration. Res. Vet. Sci. 66: 281-283
23. Moroni, P., Buronfosse, T., Longin-Sauvageon, C., Delatour, P., Benoit, E. (1995) Chiral sulfoxidation of albendazole by the flavin adenine dinucleotide-containing and cytochrome P450-dependent monooxygenases from rat liver microsomes. Drug Metab. Dispos. 23: 160-165
24. Nagy, J., Schipper, H. G., Koopmans, R. P., Butter, J. J., Van Boxtel, C. J., Kager, P. A. (2002) Effect of grapefruit juice or cimetidine coadministration on albendazole bioavailability. Am. J. Trop. Med. Hyg. 66: 260-263
25. Pourgholami, M. H., Woon, L., Almajd, R., Akhter, J., Bowery, P., Morris, D. L. (2001) In vitro and in vivo suppression of growth of hepatocellular carcinoma cells by albendazole. Cancer Lett. 165: 43-49
26. Rawden, H. L., Kokwaro, G. O., Ward, S. A., Edwards, G. (2000) Relative contribution of cytochromes P450 and flavin-containing monooxygenases to the metabolism of albendazole by human liver microsomes. Br. J. Clin. Pharmacol. 49: 313-322.
27. Redondo, P. A., Alvarez, A. I., García, J. L., Villaverde, C., Prieto, J. G. (1998) Influence of surfactants on oral bioavailability of albendazole based on the formation of the sulphoxide metabolites in rats. Biopharm. Drug Dispos. 19: 65-70
28. Redondo, P. A., Alvarez, A. I., García, J. L., Larrodé O. M., Merino, G., Prieto, J. G. (1999) Presystemic metabolism of albendazole: Experimental evidence of an efflux process of albendazole sulfoxide to intestinal lumen. Drug Metab. Dispos. 27: 736-740
29. Rolin, S., Souhaili El Amri, H., Batt, A. M., Levy, M., Bagrel, D., Siest, G. (1989) Study of the in vitro bioactivation of albendazole in human liver microsomes and hepatoma cell lines. Cell Biol. Toxicol. 5: 1-13
30. Sotelo, J. (1997) Treatment of brain cysticercosis. Surg. Neurol. 48: 110
31. Souhaili-El Amri, H., Mothe, O., Totis, M., Masson, C., Batt, A. M., Delatour, P., Siest, G. (1988) Albendazole sulfonation by rat liver cytochrome P-450c. J. Pharmacol. Exp. Ther. 246: 758-764
32. Suzuki, S., Kurata, N., Nishimura, Y., Yasuhara, H., Satoh, T. (2000) Effects of imidazole antimycotics on the liver microsomal cytochrome P450 isoforms in rats: Comparison of in vitro and ex vivo studies. Eur. J. Drug Metab. Pharmacokinet. 25: 121-126
33. Tassaneeyakul, W., Birkett, D. J., Miners, J. O. (1998) Inhibition of human hepatic cytochrome P4502E1 by azole antifungals, CNS-active drugs and non-steroidal anti-inflammatory agents. Xenobiotica 28: 293-301
34. Thummel, K. E., Wilkinson, G. R. (1998) In vitro and in vivo drug interactions involving human CYP3A. Ann. Rev. Pharmacol. Toxicol. 38: 389-430
35. Villaverde, C., Álvarez, A. I., Redondo, P., Voces, J., Del Estal, J. L., Prieto, J. G. (1995) Small intestinal sulphoxidation of albendazole. Xenobiotica 25: 433-441
36. Weiser, M. M. (1973) Instestinal epithelial cell surface membrane glycoprotein synthesis. I. An indicator of cellular differentiation. J. Biol. Chem. 248: 2536-2541
37. Wen, H., New, R. R. C., Muhmut, M., Wang, J. H., Wang, Y.H., Zhang, J. H., Shao, Y. M., Craig, P. S. (1996) Pharmacology and efficacy of liposome-entrapped albendazole in experimental secondary alveolar echinococcosis and effect of co-administration with cimetidine. Parasitology 113: 111-121
38. Whitt, D. D., Savage, D. C. (1988) Stability of enterocytes and certain enzymatic activities in suspensions of cells from the villus tip to the crypt of Lieberkühn of the mouse small intestine. Appl. Environ. Microbiol. 54: 2398-2404
39. Zulu, I., Veitch, A., Sianongo, S., McPhail, G., Feakins, R., Farthing, M. J. G., Kelly, P. (2002) Albendazole chemotherapy for AIDS-related diarrhoea in Zambia - Clinical, parasitological and mucosal responses. Aliment. Pharmacol. Ther. 16: 595-601